Immunotherapy for Stage I-II NSCLC Is Promising but Complex
Religious scholar once said,
Related Articles
Dupilumab for Atopic Dermatitis Linked to Increased Risk of Psoriasis
These findings must be weighed against the drug’s established efficacy in this disease
Duopoly in Dialysis Industry Has Grown, Raising Prices for Some Patients
Physician-chain joint ownership has also increased, raising eyebrows
An ‘Exciting’ Time for Small-Cell-Lung Cancer Treatment
When it comes to small cell lung cancer (SCLC), there are a lot of highs and lows. For instance, it has a fairly low incidence…
Opinion | CDC’s Vaccine Advisors Are Set to Vote on Thimerosal in Flu Shots
This elevates a long-standing anti-vaccine conspiracy theory
Addiction to Screen Time Tied to Suicidality in U.S. Kids
Kids with addictive use of cell phones, social media, video games have worse mental health
Proposed Medicaid Cuts Would Result in Thousands of Preventable Deaths, Study Finds
Study also shows 1.3 million would forego their medications after losing coverage
People Are Swearing Off Cold Drinks to Prevent Afib
Researchers urge greater attention to ‘cold drink heart’
Cannabis-CVD Link Holds Strong Amid Changing Drug Laws, User Habits
Real-world reports since 2016 analyzed in updated meta-analysis
Patient Safety Network Papers Restored Amid Lawsuit From Doctors
The papers had been removed from the government site over terms like ‘transgender’ and ‘LGBTQ’
FDA Approves Once-Monthly Hereditary Angioedema Drug
New option for prophylaxis is the first to target the top of the HAE cascade